ArticlePDF Available

Selection and Use of Galactogogues

Authors:
  • Nice Breastfeeding

Abstract

Breastfeeding mothers are often are concerned about an inadequate quantity of breast milk, designated as insufficient milk supply. Many breastfeeding mothers will attempt to increase the quantity of breast milk production by taking prescription drugs and/or herbs and foods called galactogogues. Galactogogues are defined simply as substances that promote lactation. The most common prescription galactogogues are domperidone, metoclopramide, metformin, and oxytocin. Many common herbals and foods have been traditionally used as galactogogues. These galactogogues will be reviewed; this information will allow health care professionals in all settings to provide consultative services to breastfeeding mothers. Breastfeeding mothers and supporters will find the information useful to determine if galactogogues are necessary, and if so, which galactogogues are appropriate for use. Treatment guidelines including benefits, doses, actions, and cautions are discussed.
192
ICAN: Infant, Child, & Adolescent Nutrition August 2015
Evidence-Based Practice Reports
Abstract: Breastfeeding mothers
are often are concerned about an
inadequate quantity of breast milk,
designated as insufficient milk supply.
Many breastfeeding mothers will attempt
to increase the quantity of breast milk
production by taking prescription
drugs and/or herbs and foods called
galactogogues. Galactogogues are defined
simply as substances that promote
lactation. The most common prescription
galactogogues are domperidone,
metoclopramide, metformin, and
oxytocin. Many common herbals and
foods have been traditionally used as
galactogogues. These galactogogues
will be reviewed; this information will
allow health care professionals in all
settings to provide consultative services
to breastfeeding mothers. Breastfeeding
mothers and supporters will find the
information useful to determine if
galactogogues are necessary, and if so,
which galactogogues are appropriate
for use. Treatment guidelines including
benefits, doses, actions, and cautions are
discussed.
Keywords: galactogogues;
domperidone; metoclopramide;
metformin; herbals; breastfeeding;
lactation
G
alactogogues may be considered
for insufficient milk supply when
nonpharmacologic interventions do
not aid in increasing milk supply.
Galactogogues typically increase prolactin
levels and thus initiate the breast milk
letdown reflex but also sometimes aid in
breast milk ejection. Multiple mechanisms
may come into play. Synthetic
galactogogues include dopamine
antagonists such as domperidone and
metoclopramide; antipsychotics such as
chlorpromazine, reserpine, sulpiride,
trifluoperazine, and thioridazine;
hormones such as oxytocin, growth
hormone, and recombinant human
prolactin; and miscellaneous agents such
as metformin.1-3 Domperidone,
metoclopramide, metformin, and oxytocin
are the most commonly used synthetic
galactogogues due to their relative efficacy
and safety in breastfeeding women. Many
herbals and foods are commonly used for
their galactogogue properties. The list is
quite extensive and includes alfalfa,
almonds, anise, asparagus, barley, basil,
beets, borage, caraway, carrots, chaste tree
fruit, cherries, chicken broth/soup/stock,
chickpeas (garbanzo beans), coconut,
coriander seeds, cumin, dandelion, dill,
fennel, fenugreek, flax seeds, garlic,
ginger, goat’s rue, green beans, hibiscus,
hops, lemon balm, lentils, lettuce,
malunggay (moringa), marshmallow root,
millet, molasses (black strap), mung,
mushrooms, nettle, oat straw (oats),
papaya, peas, pumpkin, quinoa seeds, red
clover, red raspberry, rice, sage, seaweed
soup, sesame seeds, spinach, sunflower
seeds, sweet potatoes, thistles, turmeric,
and vervain.4
Domperidone and metoclopramide are
unique antagonists of the dopamine D2
receptor site (dopamine causes a
decrease in prolactin levels), which are
used off-label to treat hypoprolactinemia
(insufficient milk supply), used to
increase prolactin levels. Of all the
prescription galactogogues, domperidone
seems to hold the most promise. Dr Tom
Hale recently obtained Orphan Drug
Status Designation from the Food and
Drug Administration (FDA) to study and
develop domperidone as a dedicated
prescription drug for the treatment of
hypoprolactinemia. Volume of milk
production per day has increased in
most, but not all, women, with increases
in milk volume occurring rapidly,
generally within 48 hours. Domperidone
rapidly facilitates prolactin release from
579718CANXXX10.1177/1941406415579718Infant, Child, & Adolescent NutritionInfant, Child, & Adolescent Nutrition
research-articleXXXX
Selection and Use of Galactogogues
Frank J. Nice, BS, MS, MPA, DPA
DOI: 10.1177/1941406415579718. Address correspondence to Frank J. Nice, Nice Breastfeeding, 7409 Algona Court, Derwood, MD 20855; e-mail: fjncat@hotmail.com.
For reprints and permissions queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.
Copyright © 2015 The Author(s)
“Many herbals and foods are commonly used for
their galactogogue properties.”
by guest on July 20, 2015can.sagepub.comDownloaded from
193
vol. 7
no. 4 ICAN: Infant, Child, & Adolescent Nutrition
the pituitary within an hour and leads to
sustained, increased plasma levels soon
after; even in nonlactating women, levels
rise almost 10-fold. Doses are usually 10
to 20 mg 4 times a day or 30 mg 3 times
a day. Most breastfeeding mothers take
the drug for 3 to 8 weeks or as long as
needed to maintain supply.5,6 A 1-page
handout, including withdrawal
algorithms, is available at www.
nicebreastfeeding.com under “Counseling
Tips.”7 An issue that limits its use is that
domperidone currently does not have
prescription status in the United States.
In addition, despite having Orphan Drug
Status designated by the FDA for
treatment of insufficient milk supply, the
FDA has tried to limit its use as an
off-label drug to increase milk supply
due to apparently unrelated cardiac
issues in a different patient population.8
Unlike metoclopramide, domperidone
does not cross the blood–brain barrier
and does not tend to have adverse
effects such as drowsiness or depression
and, especially, tardive dyskinesia.
Metoclopramide is dosed at 10 mg 3 to 4
times a day for 1 week and then
gradually decreased over the next week.
Milk supply usually increases within
several days. Mothers must empty and/or
pump breasts 6 to 8 times a day and
make sure that the breasts are emptied
completely by nursing the baby or by
using a breast pump, even at night.9
Another drug used off-label as a
galactogogue is metformin. Its action is
not known but may be related to its
precursor, galegin, which is the active
ingredient of the herbal galactogogue,
Goat’s Rue. Its dose is 500 to 2500 mg
per day taken in 2 divided doses for 3 to
10 weeks.10 All 3 reviewed drugs result
in low concentrations in breast milk that
do not affect the infant.11
A lack of letdown is rarely a problem
for breastfeeding mothers, and when it is,
pharmacological solutions are often not
needed. Many times a good latch by the
baby will solve the problem, and if not,
breast compression may help. When these
methods fail, a nasal spray containing
oxytocin may stimulate the letdown reflex
in the mother. The dosage for use is one
spray in one or both nostrils 2 to 3
minutes before nursing or pumping of
breasts. There are compounding
pharmacists in the United States who can
and will compound an oxytocin nasal
spray when the patient has a doctor’s
prescription.12 Science is rapidly
expanding in researching biologics, and
recombinant human prolactin is no
exception. In a study to determine the
efficacy of recombinant human prolactin
to treat insufficient milk supply, this
biologic apparently was efficacious for
both mothers of preterm infants with
lactation insufficiency and mothers with
prolactin deficiency. The authors
recommended that long-term safety and
efficacy studies be conducted.3
Not all mothers have access to off-label
drugs nor desire to take prescription
drugs to increase milk supply.
Galactogogue herbals and foods are
regulated by the FDA as foods and not
medicines, as long as only “affects body
function” claims and not “medical” claims
are made. Because there is easier access
to these types of galactogogues, the
necessity exists for consumers to be well
informed and have a real need for
treatment before taking any herbal. Most
knowledge for herbal use comes from
the systematic collection of data in
Germany by the German Commission E
Monographs.13 Several published texts
provide useful herbal and food
galactogogue information, including the
following: The Nursing Mother’s Herbal,14
Medications and Mothers’ Milk,11
Nonprescription Drugs for the
Breastfeeding Mother,15 and The
Galactagogue Recipe Book.4
The following represents a list of some
of the more commonly used herbal and
food galactogogues, along with usual
galactogogue dosing (for more inclusive
information, see the articles, “Common
Herbs and Foods Used as
Galactogogues”16 and “Medications and
Breastfeeding: Current Concepts,”17
available at www.nicebreastfeeding.com
under “Counseling Tips”7):
Alfalfa (Medicago sativa): Up to 60 g
daily (1-2 capsules 4 times a day)
Anise (Anisi fructus): 3.5 to 7 g as
tincture or tea, 5 to 6 times a day
Barley (Hordeum vulgare): 15 g of
barley extract, 1 cup to 2 cups of
tea daily; 1 bottle of beer daily
Blessed Thistle (Cnici benedicti herba):
Up to 2 g, in capsule form, daily
Caraway (Carvi fructus): 1.5 to 6 g
daily as tincture, tea, or essential oil
Chaste Tree Fruit, Chasteberry, Vitex
(Agni casti fructus): 30 to 40 mg
daily as an alcoholic extract (50%
to 70% alcohol)
Coriander, Cilantro (Coriander
fructus): 3 g daily as tea
Dandelion (Taraxaci herba): 5 g, in
capsule form or as tincture or tea,
3 times a day
Dill (Anethi fructus): 3 g daily as
tincture or tea
Fennel (Foeniculi fructus): 0.1 to 0.6 mL
of oil (equal to 100-600 mg) daily
Fenugreek (Foenugraeci semen): 6 g,
in capsule form, daily
Garlic (Allii sativa bulbus): 4 to 9 g,
in capsule form, daily
Goat’s Rue (Galegae officinalis
herba): 1 to 2 mL of tincture, 2 to
3 times a day
Hops (Lupuli strobulus): 500 mg of dry
extract daily, 1 cup to 2 cups of tea
daily, 1 bottle of stout beer daily
Malunggay, Moringa (Moringa
oleifara): 250 mg, in capsule form
or as tea, 2 times a day
Marshmallow Root (Althaeae radix):
Two 500 mg capsules 3 times a
day or 60 g daily as tincture or tea
Milk Thistle (Cardui mariae herba):
12 to 15 g daily as infusion (equal
to 200-400 mg of silibinin
Oat Straw, Oats (Avenae
stramentum): 100 g daily
Quinoa (Chenopodium quinoa): 45 g
daily
Red Raspberry (Rubi idaei folium): 2.7
g as three 300 mg capsules 3 times
a day or daily as tincture or tea
Red Clover (Trifolium pretense): 40 to
80 mg daily as tincture or tea
Stinging Nettle (Urtica dioica and
Urtica urens): 1.8 g as one 600 mg
capsule 3 times a day, 1 cup of tea
2 to 3 times a day, 2.5 to 5 mL of
tincture 3 times a day
Vervain (Verbena officinalis): 30 to
50 g daily as tea
by guest on July 20, 2015can.sagepub.comDownloaded from
194
ICAN: Infant, Child, & Adolescent Nutrition August 2015
The doses mentioned above represent
medicinal doses. Food equivalent
amounts of these herbals and many
others can be found in The Galactagogue
Recipe Book.4
As readers of this journal know,
breastfeeding has innumerable positive
health implications for breastfeeding
mothers and children. Therefore,
breastfeeding is recommended for all
willing and able mothers and infants.
Yet there are ever-present obstacles to
successful breastfeeding, even with the
most motivated mothers. One major
obstacle is the prevalence of
insufficient milk supply, which may be
as high as 15% in new mothers.3 The
causes are many, and all possible
causes should be investigated and
considered. As part of this consultative
evaluation, the selection and use of
galactogogues can be a viable and
reasonable choice. Information
presented in this article can be the
basis for making objective and
informative decisions.
Author Note
The author(s) declared no potential conflicts of
interest with respect to the research, authorship,
and/or publication of this article.
References
1. Forinash AB, Yancey AM, Barnes KN,
Myles TD. The use of galactogogues in the
breastfeeding mother. Ann Pharmacother.
2012;46:1392-1404.
2. Zuppa AA, Sindico P, Orchi C, Carducci
C, Cardiello V, Romagnoli C. Safety and
efficacy of galactogogues: substances
that induce, maintain and increase breast
milk production. J Pharm Pharm Sci.
2010;13:162-174.
3. Powe C, Allen M, Puopolo K. Recombinant
human prolactin for the treatment of
lactation insufficiency. Clin Endocrin (Oxf).
2010;73:645-653.
4. Nice FJ. The Galactagogue Recipe Book.
Plano, TX: Hale Publishing; 2014.
5. Campbell-Yeo MI, Allen AC, Joseph
KS, et al. Effect of domperidone on the
composition of preterm human milk.
Pediatrics. 2010;125:107-114.
6. Wan EW, Davey K, Page-Sharp M,
Hartmann PE, Simmer K, Ilett KF.
Dose-effect study of domperidone as
a galactogogue in preterm mothers
with insufficient milk supply, and its
transfer into milk. Br J Clin Pharmacol.
2008;66:283-289.
7. Nice Breastfeeding. Counseling tips. www.
nicebreastfeeding.com. Accessed January 6,
2015.
8. ILCA Consensus on Domperidone to
Support Lactation. http://rcp.nshealth.ca/
news/ilca-consensus-domperidone-support-
lactation. Accessed January 6, 2015.
9. Hansen WF, McAndrew S, Harris K,
Zimmermann MB. Metoclopramide effect
on breastfeeding the preterm infant:
a randomized trial. Obstet Gynecol.
2005;105:383-389.
10. Glueck CJ, Salehi M, Sieve I, Wang P.
Growth, motor, and social development
in breast- and formula-fed infants of
metformin-treated women with polycystic
ovary syndrome. J Pediatr. 2006;148:
628-632.
11. Hale TW, Rowe HE. Medications and
Mothers’ Milk. 16th ed. Plano, TX: Hale
Publishing; 2014.
12. University of Washington Medical Chapter.
Oxytocin nasal spray. https://healthonline.
washington.edu/document/health_online/
pdf/09-Oxytocin_Nasal_Spray_8_09.pdf.
Accessed January 6, 2015.
13. Blumenthal M, Busse WR, Goldberg A,
et al, eds. The Complete Commission E
Monographs: Therapeutic Guide to Herbal
Medicines. Austin, TX: American Botanical
Society; 1998.
14. Humphrey S. The Nursing Mother’s Herbal.
Minneapolis, MN: Fairview Press; 2003.
15. Nice FJ. Nonprescription Drugs for the
Breastfeeding Mother. 2nd ed. Amarillo, TX:
Hale Publishing; 2011.
16. Nice FJ. Common herbs and foods used as
galactogogues. Infant Child Adolesc Nutr.
2011;3:129-132.
17. Nice FJ, Luo AC. Medications and
breastfeeding: current concepts. J Am
Pharm Assoc (2003). 2012;52:86-94.
by guest on July 20, 2015can.sagepub.comDownloaded from
... Furthermore, as lettuce has diuretic, laxative, moisturizing and thirst-quenching effects [40][41][42] . It is also known broadly to be one of the things that can increase milk production 33,35,36,43,44 . Nevertheless, its effect upon human milk production is yet to be tested exclusively. ...
... As this is the first study of its kind, articles presenting comparative results remain unavailable. Nevertheless, in Ibn Sina's book (Canon medicine) and according to evidence-based practical reports of Nice in 2015, lettuce is one of the things that is known to increase milk production 33,35,36 . Lettuce contains phytoestrogens 34 , flavonoid compounds 37 and Lignans. ...
Article
Full-text available
Human milk feeding can support premature infants to thrive. Yet those with premature infants can be challenged in human milk production. Considering this, and the use of potentially harmful human milk enhancers, the present study was conducted with the aim of determining the effect of orally consumed Lactuca sativa (L. sativa) syrup (lettuce extract) on human milk volume and subsequent weight gain in the preterm infant. Extracts from lettuce and other plants such as silymarin are already evidenced to be safe for use during lactation and have other therapeutic effects in humans. Yet this is the first study of its kind. This parallel randomized clinical trial included lactating participants with their preterm infants who were born at < 32 weeks' gestation and admitted to an intensive care unit. Convenience sampling was used to recruit participants. Eligible participants were allocated to groups randomly: intervention (n = 47), placebo (n = 46), and control (n = 47). The intervention group received one tablespoon of Lactuca sativa (L. sativa) syrup, and the placebo group received one tablespoon of placebo syrup 3 times a day for 1 week. Those in the control group did not receive any herbal or chemical milk-enhancing compounds. Routine care was provided to all three groups. Participants recorded their milk volume for 7 days in a daily information recorder form. Infant weight was measured prior to the intervention, and on the third, fifth and seventh days of the intervention period. There was a statistically significant difference observed in the adjusted mean volume of milk on the fourth and fifth days between the intervention, placebo, and control groups (P < 0.05). The adjusted mean milk volume of those in the intervention group on the first day was significantly higher than those in the control group and those in the placebo group. On the second day, the adjusted mean milk volume of those in the intervention group was higher than in those from the control group; and on the fourth day it was higher than in those from both the control and placebo groups; on the fifth day it was higher than in those in the placebo group; on the sixth day it was higher than in those in the control group and on the seventh day it was higher than in those in the control group (P < 0.05). There was no statistically significant difference in terms of the mean changes (with or without adjustment) in the weight of preterm infants between any of the groups. Lactuca sativa (L. sativa) syrup increases the volume of human milk production and no specific side effects have been reported in its use. Therefore, Lactuca sativa syrup can be recommended for use as one of the compounds that increase human milk volume.
... Some herbs that are used include fenugreek, goat's rue, milk thistle (Silybum marianum), oats, dandelion, millets, seaweed, anise, basil, blessed thistle, fennel seeds, and marshmallow among others [14]. Nice (2015) [15] reported that a wide variety of foods and herbals are used for their galactagogic properties. These include alfalfa, almonds, anise, asparagus, barley, basil, beets, borage, caraway, carrots, chaste tree fruit, cherries, chicken broth/soup/stock, chickpeas (garbanzo beans), coconut, coriander seeds, cumin, dandelion, dill, fennel, fenugreek, flax seeds, garlic, ginger, goat's rue, green beans, hibiscus, hops, lemon balm, lentils, lettuce, malunggay/ drumstick (moringa), marshmallow root, millet, molasses (blackstrap), mung, mushrooms, nettle, oat straw (oats), papaya, peas, pumpkin, quinoa seeds, red clover, red raspberry, rice, sage, seaweed soup, sesame seeds, spinach, sunflower seeds, sweet potatoes, thistles, turmeric, and vervain. ...
Article
Full-text available
Introduction: India has a tremendous food culture with varied regional cuisines. All communities value certain foods for their health and medicinal benefits. There are many regional and community-wise dietary practices recommended for pregnant and lactating women. In Gujarat, Katlu is a traditional postpartum polyherbal formulation. Similar preparations are given in other states also. In Gujarat, this formulation is also consumed during winter by persons of all ages. Methods: The ingredients for preparation of katlu powder in Gujarat were identified from records dating back to the 19th century maintained by an Ayurvedic practitioner, and from 17 commercial dealers. Information on how Katlu is provided to the mothers was recorded. The possible health benefits of the ingredients were studied from Ayurvedic texts and published scientific evidence. Results and Discussion: While the traditional formulation is supposed to contain 32 plant materials, it was observed that none of the commercially available powders contained all 32 plant materials. Majority contained 10-12 of the ingredients. One or two products contained a variety of other plant materials not listed in the original formulation. Katlu is incorporated into a local sweet preparation providing considerable energy and moderate protein. Besides containing herbs with galactagogic properties, Katlu contains plant materials with other health benefits e.g., anti-inflammatory. However, there are no studies on this formulation per se. Conclusion: Katlu appears to have numerous health benefits and merits scientific investigation. This functional food and its health value should be promoted in the community and among nutrition and public health professionals.
... Few have been listed as -asparagus, barley, basil leaves & seeds, beets, borage, caraway, vegetables like carrots, cherries, chickpeas, coconut, coriander seeds, cumin, dandelion, dill, fennel, fenugreek, flax seeds, garlic, ginger, alfalfa, almonds, star-anise, green beans, hibiscus, hops, lemon balm, lentils, lettuce, malunggay (Moringa), marshmallow root, millets, molasses (black strap), mushrooms, nettle, oat straw (oats), papaya, peas, pumpkin, quinoa seeds, red raspberry, rice, sage, seaweed soup, sesame seeds, spinach, sunflower seeds, sweet potatoes, thistles, turmeric, and vervain and many more. 3 Ethnomedicinally, these plants have been used to provide a natural ability to support lactation. Various tribes, cultural practices, and regions are known to use these plants. ...
Article
Full-text available
The functional potential of plants and plant-based components have been used in different cultures since time immemorial to promote milk production in women. Conditions like agalactia or insufficient production of breast milk due to various barriers intended to be a greater risk of weight loss for neonates and prompting for supplementation of infant formula. Multiple plants are traditionally used worldwide as galactagogues during the lactation period. This study aims to extract information on traditionally used galactagogue plants and compare their ethnopharmacological evidence with scientific evidence. This will help to understand the gaps in the ethnopharmacological and scientific data and thus provide future research information.Information on traditional and scientific studies was collected and analyzed on galactagogues. The ethnopharmacological data of the focused plant species were analyzed for part used, formulations, and region of its uses. All cultures traditionally used natural products as galactagogue from times immemorial, and due to scientific advances, these have also been seen as commercial products. However, because of the limited studies, it is of interest to standardize the doses, and composition of bioactive components and study the mechanism of action, its side effects, and interaction with food. This is a forward-looking research area that could be projected for manufacturing herbal formulations for lactating mothers.
... Additionally, in the absence of breastfeeding counseling and non-pharmacological strategies, researchers' attention to the use of chemical and herbal milk supplements has increased [14,20]. In many parts of the world, herbal medicines have been used for the augmentation of human milk during postpartum period [21,22]. Pimpinella Anisum or ' Aniseed/Anise' in traditional medicine is already established to have many therapeutic benefits in humans including being an antioxidant, antibacterial, antifungal, anticonvulsant, anti-inflammatory, analgesic, gastro-protective, antidiabetic, and antiviral [23,24]. ...
Article
Full-text available
Background and aims Human milk supports pre-term infants to thrive. Yet human milk production can be inhibited when infants are born prematurely. Pimpinella Anisum has been evidenced to increase milk production and infant weight gain in previous animal studies. The present study aimed to determine the effect of Pimpinella Anisum herbal tea on human milk volume and preterm infant weight in human populations for the first time. Methods Human milk supports pre-term infants to thrive. Yet human milk production can be inhibited when infants are born prematurely. Pimpinella Anisum has been evidenced to increase milk production and infant weight gain in previous animal studies. The present study aimed to determine the effect of Pimpinella Anisum herbal tea on human milk volume and preterm infant weight in human populations for the first time. Results There was a statistically significant difference in terms of milk volume in the first, third, fourth, fifth, sixth and seventh days between the three groups of intervention, placebo, and control ( p < 0.05). On the first day, the mean volume of pumped milk in the intervention group was significantly higher than the control group ( p = 0.008). On the second day, there was no statistically significant difference between groups. On the third, fourth, fifth, sixth and seventh days, the mean volume of pumped milk in the intervention group was significantly higher than the placebo and control groups ( p < 0.05). There was no statistically significant difference in terms of preterm infant weight on days 0, 3 and 7 between the three groups. Conclusion The use of Pimpinella Anisum or ‘Anise’ tea can increase the volume of human milk and since no specific side effects have been reported in its use, it may be incorporated easily, cheaply, and effectively in practice where appropriate to the benefit of preterm infant nutrition worldwide.
... Badania kliniczne przeprowadzone z udziałem kobiet wykazały, iż spożycie piwa bezalkoholowego na bazie jęczmienia, wpłynęło u nich na zwiększenie wydzielania prolaktyny o 10% [5,9]. Powszechnie uważa się, że spożycie 15,0 g ekstraktu jęczmiennego w postaci jednej do dwóch filiżanek herbaty dziennie lub butelki piwa bezalkoholowego dziennie, jest w stanie wywołać u kobiet karmiących efekt mlekopędny [32]. ...
Article
Full-text available
Część kobiet po urodzeniu dziecka boryka się z problemem wytwarzania mleka w niewystra-czającej ilości i nie jest w stanie wykarmić dziecka wyłącznie na swoim naturalnym pokarmie. Sytuacja ta zmusza je więc do wprowadzenia do diety noworodka mleka modyfikowanego lub poszukiwania sposobu na zwiększenie laktacji. Powszechnie wiadomo, iż mleko matki zapewnia noworodkowi optymalną podaż składników odżywczych, zwiększa jego odporność i wpływa korzystnie na jego dalszy rozwój. Ze względu na brak leku syntetycznego, przeznaczonego dla kobiet karmiących w celu zwiększenia laktacji, wiele kobiet zwraca się ku lekowi roślinnemu. Duża część surowców roślinnych mająca wpłynąć na zwiększenie laktacji stosowana jest jako tradycyjne produkty lecznicze. Należy jednak zwrócić uwagę na brak wystarczającej liczby badań naukowych przeprowadzonych z udziałem matek karmiących potwierdzających ich mlekopędne działanie. Dodatkowo brak jest badań przeprowadzonych z udziałem noworodków potwierdzających, iż surowiec roślinny nie przenika do mleka matki lub w momencie przenikania wykazuje odpowiedni profil bezpieczeństwa dla tak małego dziecka. Celem niniejszego przeglądu literaturowego było sprawdzenie, które surowce roślinne, uważane powszechnie za mlekopędne, wykazują takie właściwości również w badaniach klinicznych oraz czy zbadano już ich profil bezpieczeństwa zarówno w stosunku do matki karmiącej, jak i jej dziecka.
Article
Background Hypogalactia and agalactia in lactating mothers are the major causes of child malnutrition, mortality, morbidity, and overall ill health. The development of such treatments requires a well-designed preclinical study with suitable laboratory animals, which needs to be improved. Thus, a suitably designed study with a laboratory animal to analyse galactagogue activity, along with an assessment of the quality and quantity of milk, is required. Objectives This study aimed to evaluate the potential of rabbits as an animal model for studying lactogenic activity. Methods The structural homology of prolactin, prolactin, and prolactin in humans, rabbits, and rats was studied using BLAST and PyMol to assess similarity in the lactogenic system. Daily and cumulative milk production and pre-treatment (control) and post-treatment (three drugs) in rabbits were recorded and evaluated by analysing protein, fat, lactose, solid non-fat, and ash values. All parameters were recorded on the 0th day and at the end of weeks 1, 2, and 3. Mammary gland histopathology was performed to evaluate the effects on mammary glands. Results Homology studies revealed that the sequences of the human and rabbit prolactin genes, receptors, and hormones had a high similarity index. Treatment with Domperidone, Metoclopramide, and Shatavari significantly enhanced milk production by enhancing prolactin secretion; only Shatavari increased milk nutrition. Enlargement of the tubuloalveolar ducts of the mammary glands was observed. Conclusion Our findings suggest that rabbits are robust, reproducible, ethically superior, and preclinically relevant animals for assessing lactogenic activity.
Article
Background Acne vulgaris is a common dermatological condition that greatly impacts patients’ self-confidence. Ongoing research is conducted to explore new treatment modalities. Silymarin owns special characteristics that qualify it as a possible treatment for acne vulgaris. Objective We evaluated the efficacy and safety of silymarin cream as a new therapeutic option against salicylic acid peels in the treatment of mild to moderate acne vulgaris. Methods A split-face, comparative, Quasi-experimental clinical trial included 30 patients with acne vulgaris. Salicylic acid 30% peels were applied as an office procedure to one half of the face every 2 weeks for 3 months. Topical silymarin 1.4% cream was prescribed as a home treatment, twice daily, to the other half of the face for 3 months. The results were evaluated using the Global Acne Grading System (GAGS), photographic evaluation, and patient self-assessment scale. The adverse effects during treatment were recorded. The sample size was calculated by Stata/IC 16.1. Results After treatment, a significant reduction of GAGS was noted on both sides of the face, with an insignificant difference between both treatments. The comparative photographic evaluation and patient self-assessment scale were also insignificant. Hyperpigmentation was recorded in 2 cases on the salicylic acid-treated side. No side effects for silymarin cream were observed. Conclusion Topical silymarin cream 1.4% showed comparable results to Salicylic acid 30% peels. It can be considered a promising safe treatment modality for mild to moderate acne vulgaris.
Article
Full-text available
The research objectives were to measure the concentration of progesterone and prolactin hormone and milk production of New Zealand White rabbit’s doe fed with moringa leaves meal. Blood sample was taken and centrifuged to separate serum and plasma. Then, the blood serum was analyzed applying ELISA method using ELISA kit EIA 1561 for progesterone hormone and rabbit prolactin ELISA kit cat no. E-EL-RB1223 for prolactin hormone. The milk production was measured daily by weighting the body weight of rabbit kids before and after milking. Data analysis using anova method applying program SPSS version 20 for windows. Moringa leaves meal fed tends to increase the concentration of progestrone hormone during pregnancy period and it decline sharply in post natal. The higher the level of moringa leaves meal, the higher the production of prolactin hormone at natal period. This fact doe to amino acids content of moringa leaf meal particularly essential amino acids. The main function of amino acid was in hormone and transmitter synthesis. Decrease of prolactin inhibitor and increase of prolactin secretion at natal period as an effect of amino acids content in moringa leaves meal. Increasing of prolactin level will followed by milk excretion. Increase of milk production caused by galactogogue effect of moringa leaves meal. The increasing of moringa leaves meal level influences milk production in milking period and produces a higher body weight at post weaning period comparing with without the moringa leaves meal. Using moringa leaves meal is suggested in order it increase livestock milk production in dry land areas to overcome kid’s mortality problem.
Article
Background Preterm mothers face unique challenges—the stress of preterm delivery and their premature babies’ inability to suckle directly from the breasts, culminating in poor milk supply. Galactogogues are substances believed to enhance human milk production. Evidence for their use in preterm mothers is insufficient. Research aims To (a) evaluate the influence of galactogogues on milk production among mothers with preterm birth, and (b) assess the safety of galactogogues for mother-infant dyads. Methods A systematic search was conducted between January 2018 and May 2019 in nine electronic databases, with manual searches through reference lists of included articles. Randomized controlled trial studies addressing outcome measure of milk quantification were selected. Seven trials met the inclusion criteria and, using the Clinical Appraisal Skills program checklists and the modified Cochrane Collaboration tool for assessing risk of bias, each trial was critically appraised for content, bias in methodology, and reporting. Results Four herbal substances (fenugreek, silymarin, silymarin/galega, and stinging nettle) and domperidone used in intervention studies were analyzed. Fenugreek and silymarin used in isolation did not yield significant increase in milk production, while the combination herbal mixtures silymarin/galega and stinging nettle herbal tea increased milk production. Domperidone use resulted in an acute increase in milk production, which was not sustained with prolonged use. The reviewed studies reported no serious adverse effects on mother-infant dyads. Conclusion Herbal galactogogues may be more effective for longer term use, although there is still limited evidence to support its prescription to preterm mothers. Larger studies are required.
Article
Background: Many women express concern about their ability to produce enough milk, and insufficient milk is frequently cited as the reason for supplementation and early termination of breastfeeding. When addressing this concern, it is important first to consider the influence of maternal and neonatal health, infant suck, proper latch, and feeding frequency on milk production, and that steps be taken to correct or compensate for any contributing issues. Oral galactagogues are substances that stimulate milk production. They may be pharmacological or non-pharmacological (natural). Natural galactagogues are usually botanical or other food agents. The choice between pharmacological or natural galactagogues is often influenced by familiarity and local customs. Evidence for the possible benefits and harms of galactagogues is important for making an informed decision on their use. Objectives: To assess the effect of oral galactagogues for increasing milk production in non-hospitalised breastfeeding mother-term infant pairs. Search methods: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register, ClinicalTrials.gov, the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), Health Research and Development Network - Phillippines (HERDIN), Natural Products Alert (Napralert), the personal reference collection of author LM, and reference lists of retrieved studies (4 November 2019). Selection criteria: We included randomised controlled trials (RCTs) and quasi-RCTs (including published abstracts) comparing oral galactagogues with placebo, no treatment, or another oral galactagogue in mothers breastfeeding healthy term infants. We also included cluster-randomised trials but excluded cross-over trials. Data collection and analysis: We used standard Cochrane Pregnancy and Childbirth methods for data collection and analysis. Two to four review authors independently selected the studies, assessed the risk of bias, extracted data for analysis and checked accuracy. Where necessary, we contacted the study authors for clarification. Main results: Forty-one RCTs involving 3005 mothers and 3006 infants from at least 17 countries met the inclusion criteria. Studies were conducted either in hospitals immediately postpartum or in the community. There was considerable variation in mothers, particularly in parity and whether or not they had lactation insufficiency. Infants' ages at commencement of the studies ranged from newborn to 6 months. The overall certainty of evidence was low to very low because of high risk of biases (mainly due to lack of blinding), substantial clinical and statistical heterogeneity, and imprecision of measurements. Pharmacological galactagogues Nine studies compared a pharmacological galactagogue (domperidone, metoclopramide, sulpiride, thyrotropin-releasing hormone) with placebo or no treatment. The primary outcome of proportion of mothers who continued breastfeeding at 3, 4 and 6 months was not reported. Only one study (metoclopramide) reported on the outcome of infant weight, finding little or no difference (mean difference (MD) 23.0 grams, 95% confidence interval (CI) -47.71 to 93.71; 1 study, 20 participants; low-certainty evidence). Three studies (metoclopramide, domperidone, sulpiride) reported on milk volume, finding pharmacological galactagogues may increase milk volume (MD 63.82 mL, 95% CI 25.91 to 101.72; I² = 34%; 3 studies, 151 participants; low-certainty evidence). Subgroup analysis indicates there may be increased milk volume with each drug, but with varying CIs. There was limited reporting of adverse effects, none of which could be meta-analysed. Where reported, they were limited to minor complaints, such as tiredness, nausea, headache and dry mouth (very low-certainty evidence). No adverse effects were reported for infants. Natural galactagogues Twenty-seven studies compared natural oral galactagogues (banana flower, fennel, fenugreek, ginger, ixbut, levant cotton, moringa, palm dates, pork knuckle, shatavari, silymarin, torbangun leaves or other natural mixtures) with placebo or no treatment. One study (Mother's Milk Tea) reported breastfeeding rates at six months with a concluding statement of "no significant difference" (no data and no measure of significance provided, 60 participants, very low-certainty evidence). Three studies (fennel, fenugreek, moringa, mixed botanical tea) reported infant weight but could not be meta-analysed due to substantial clinical and statistical heterogeneity (I2 = 60%, 275 participants, very low-certainty evidence). Subgroup analysis shows we are very uncertain whether fennel or fenugreek improves infant weight, whereas moringa and mixed botanical tea may increase infant weight compared to placebo. Thirteen studies (Bu Xue Sheng Ru, Chanbao, Cui Ru, banana flower, fenugreek, ginger, moringa, fenugreek, ginger and turmeric mix, ixbut, mixed botanical tea, Sheng Ru He Ji, silymarin, Xian Tong Ru, palm dates; 962 participants) reported on milk volume, but meta-analysis was not possible due to substantial heterogeneity (I2 = 99%). The subgroup analysis for each intervention suggested either benefit or little or no difference (very low-certainty evidence). There was limited reporting of adverse effects, none of which could be meta-analysed. Where reported, they were limited to minor complaints such as mothers with urine that smelled like maple syrup and urticaria in infants (very low-certainty evidence). Galactagogue versus galactagogue Eight studies (Chanbao; Bue Xue Sheng Ru, domperidone, moringa, fenugreek, palm dates, torbangun, moloco, Mu Er Wu You, Kun Yuan Tong Ru) compared one oral galactagogue with another. We were unable to perform meta-analysis because there was only one small study for each match-up, so we do not know if one galactagogue is better than another for any outcome. Authors' conclusions: Due to extremely limited, very low certainty evidence, we do not know whether galactagogues have any effect on proportion of mothers who continued breastfeeding at 3, 4 and 6 months. There is low-certainty evidence that pharmacological galactagogues may increase milk volume. There is some evidence from subgroup analyses that natural galactagogues may benefit infant weight and milk volume in mothers with healthy, term infants, but due to substantial heterogeneity of the studies, imprecision of measurements and incomplete reporting, we are very uncertain about the magnitude of the effect. We are also uncertain if one galactagogue performs better than another. With limited data on adverse effects, we are uncertain if there are any concerning adverse effects with any particular galactagogue; those reported were minor complaints. High-quality RCTs on the efficacy and safety of galactagogues are urgently needed. A set of core outcomes to standardise infant weight and milk volume measurement is also needed, as well as a strong basis for the dose and dosage form used.
Article
Full-text available
Historically, herbs and foods have been used as galactogogues by breastfeeding women to maintain and increase milk supply. Commonly used herbs and foods used as galactogogues are reviewed. Doses, other uses for taking herbals by breastfeeding mothers, and cautions to observe when using these galactogogues are discussed. This information can be used by health care professionals as general guidelines to counsel lactating mothers who wish to use or are already using herbals or consuming foods to stimulate milk supply. A brief mention of prescription galactogogue alternatives is provided. Sources of currently available nonprescription galactogogue information are listed. This information will be useful for community, clinic, hospital, and other health care settings where consultative services are provided to breastfeeding mothers. Utilization of the information provided will allow health care professionals to counsel mothers on the use of herbals and foods as galactogogues.
Article
Full-text available
To review data regarding the efficacy of galactogogues available in the US to increase breast milk production in postpartum mothers. Literature was sought using PubMed (1966-June 2012) and EMBASE (1973-June 2012). Search terms included breastfeeding, breast milk, lactation, galactogogue, metoclopramide, oxytocin, fenugreek, milk thistle, silymarin, growth hormone, thyroid releasing hormone, medroxyprogesterone, domperidone, goat's rue, beer, Asparagus racemosus, shatavari, Medicago sativa, alfalfa, Onicus benedictus, blessed thistle, Galega officinalis, brewer's yeast, and herbals. All studies including humans and published in English with data assessing the efficacy of galactogogues for increasing breast milk production were evaluated. Breast milk is considered the optimal food source for newborns through 1 year of age. Many factors influence overall maternal production, including maternal pain, illness, balance of time when returning to work, anxiety, or emotional stress. Although a variety of herbal and pharmaceutical options have anecdotal evidence of their ability to improve breast milk production, peer-reviewed studies proving their efficacy are lacking. Metoclopramide, oxytocin, fenugreek, and milk thistle have shown mixed results in improving milk production; however, the trials were small and had a variety of limitations. Nonpharmacologic recommendations should be exhausted before adding therapy. Although anecdotal evidence encourages the use of metoclopramide, fenugreek, asparagus, and milk thistle for their galactogogue properties, efficacy and safety data in the literature are lacking. Oxytocin and domperidone are potentially available for compounding purposes, but safety data are limited. More studies are needed to evaluate the effects of available galactogogues on breast milk production.
Article
Full-text available
To describe the various factors that come into play when a breast-feeding mother is taking medications, including use of prescription drugs, over-the-counter medications, recreational drugs, galactogogues, and herbal remedies and to provide a framework used for counseling breast-feeding women. Community and hospital pharmacy and health care settings. Consultative services provided to breast-feeding mothers who had been prescribed or were using medications. Use of pharmacokinetic factors, maternal and child factors, a list of questions to ask breast-feeding mothers, and a stepwise approach to counsel breast-feeding mothers on the compatibility of using medications while breast-feeding. By positive intervention of pharmacists and health care providers, up to 1 million breast-feeding mothers, who must use medications, can continue to breast-feed while taking medications. Objectively weighing the benefits of drugs and breast-feeding versus the risks of drugs and not breast-feeding, in most cases, allows for pharmacists to give current and practical advice to mothers and other health professionals who counsel mothers.
Article
Full-text available
Poor production of breast milk is the most frequent cause of breast lactation failure. Often, physician prescribe medications or other substances to solve this problem. The use of galactogogues should be limited to those situations in which reduced milk production from treatable causes has been excluded. One of the most frequent indication for the use of galactogogues is the diminution of milk production in mothers using indirect lactation, particularly in the case of preterm birth. The objective of this review is to analyze to the literature relating to the principal drugs used as galactogogues (metoclopramide, domperidone, chlorpromazine, sulpiride, oxytocin, growth hormone, thyrotrophin releasing hormone, medroxyprogesterone). Have been also analyzed galactogogues based on herbs and other natural substances (fenugreek, galega and milk thistle). We have evaluated their mechanism of action, transfer to maternal milk, effectiveness and potential side effects for mother and infant, suggested doses for galactogogic effect, and recommendation for breastfeeding.
Article
Full-text available
Domperidone is increasingly prescribed to improve breast milk volume despite a lack of evidence regarding its effects on breast milk composition. We examined the effect of domperidone on the nutrient composition of breast milk. Forty-six mothers who had delivered infants at <31 weeks' gestation, who experienced lactation failure, were randomly assigned to receive domperidone or placebo for 14 days. Protein, energy, fat, carbohydrate, sodium, calcium, and phosphate levels in breast milk were measured on days 0, 4, 7, and 14, serum prolactin levels were measured on days 0, 4, and 14, and total milk volume was recorded daily. Mean within-subject changes in nutrients and milk volumes were examined. Maternal and infant characteristics, serum prolactin level, and breast milk volume and composition were not significantly different between domperidone and placebo groups on day 0. By day 14, breast milk volumes increased by 267% in the domperidone-treated group and by 18.5% in the placebo group (P = .005). Serum prolactin increased by 97% in the domperidone group and by 17% in the placebo group (P = .07). Mean breast milk protein declined by 9.6% in the domperidone group and increased by 3.6% in the placebo group (P = .16). Changes in energy, fat, carbohydrate, sodium, and phosphate content were also not significantly different between groups. Significant increases were observed in breast milk carbohydrate (2.7% vs -2.7%; P = .05) and calcium (61.8% vs -4.4%; P = .001) in the domperidone versus placebo groups. No significant adverse events were observed among mothers or infants. Domperidone increases the volume of breast milk of preterm mothers experiencing lactation failure, without substantially altering the nutrient composition.
Article
Objectives In a prospective, 6-month study of 61 breast- and 50 formula-fed infants born to 92 PCOS mothers, all of whom took metformin throughout pregnancy, our hypothesis was that metformin during lactation vs formula would have no adverse effects on infants' growth, motor-social development, and intercurrent illness. Study Design Growth, motor-social development, and illness requiring a pediatrician visit were prospectively assessed in 61 nursing infants (21 male, 40 female) and 50 formula-fed infants (19 male, 31 female) born to 92 PCOS mothers taking a median of 2.55 g metformin/day throughout pregnancy and lactation. Results Within gender, at 3 and 6 months of age, weight, height, and motor-social development did not differ ( p $ .06) between breast- and formula-fed infants. No infants had retardation of growth, motor, or social development. Intercurrent illnesses did not differ in 30% of breast- and 22% of formula-fed infants by 3 months ( p = .4) and in 46% and 34% by 6 months ( p = .2). Conclusions Growth, motor-social development, and intercurrent illnesses in breast- and formula-fed infants from metformin-treated PCOS mothers did not differ; metformin during lactation appears to be safe and effective in the first 6 months of infancy.
Article
Lactation insufficiency has many aetiologies including complete or relative prolactin deficiency. Exogenous prolactin may increase breast milk volume in this subset. We hypothesized that recombinant human prolactin (r-hPRL) would increase milk volume in mothers with prolactin deficiency and mothers of preterm infants with lactation insufficiency. Study 1: R-hPRL was administered in an open-label trial to mothers with prolactin deficiency. Study 2: R-hPRL was administered in a randomized, double-blind, placebo-controlled trial to mothers with lactation insufficiency that developed while pumping breast milk for their preterm infants. Study 1: Mothers with prolactin deficiency (n = 5). Study 2: Mothers of premature infants exclusively pumping breast milk (n = 11). Study 1: R-hPRL (60 μg/kg) was administered subcutaneously every 12 h for 28 days. Study 2: Mothers of preterm infants were randomized to receive r-hPRL (60 μg/kg), placebo or r-hPRL alternating with placebo every 12 h for 7 days. Change in milk volume. Study 1: Peak prolactin (27·9 ± 17·3 to 194·6 ± 19·5 μg/l; P < 0·003) and milk volume (3·4 ± 1·6 to 66·1 ± 8·3 ml/day; P < 0·001) increased with r-hPRL administration. Study 2: Peak prolactin increased in mothers treated with r-hPRL every 12 h (n = 3; 79·3 ± 55·4 to 271·3 ± 36·7 μg/l; P < 0·05) and daily (101·4 ± 61·5 vs 178·9 ± 45·9 μg/l; P < 0·04), but milk volume increased only in the group treated with r-hPRL every 12 h (53·5 ± 48·5 to 235·0 ± 135·7 ml/day; P < 0·02). Twice daily r-hPRL increases milk volume in mothers with prolactin deficiency and in preterm mothers with lactation insufficiency.
Article
To investigate the effect of metoclopramide on breast milk volume and duration of breastfeeding in women delivering preterm. Women who planned to breastfeed and delivered between 23 and 34 weeks of gestation were eligible to participate in this randomized, double-blind, placebo-controlled study. Women were randomized to receive 10 mg of metoclopramide or placebo 3 times a day for 10 days, starting within 96 hours of birth. Breastfeeding education was standardized for all women. Mothers recorded the volume of breast milk expressed at each pumping for 17 days. Duration of breastfeeding was measured by monthly follow-up phone calls to each subject. Sixty-nine women were enrolled and 57 (82%) women completed the study: 28 in the metoclopramide group and 29 in the placebo group. The 2 groups were similar in age, education, ethnicity, gestational age, and marital status. There was no significant difference between breast milk volumes in the metoclopramide and placebo groups at each of the 17 days of the study (P = .26 to .98; test for mean metoclopramide effect P = .80). There was no significant difference between groups in duration of breastfeeding, with a median of 8.8 weeks, an interquartile range of 3.4 to 12.0 weeks for the metoclopramide group and a median of 8.6 weeks, and an interquartile range of 5.6 to 16.9 weeks for the placebo group (P = .09). Metoclopramide did not improve breast milk volume or duration of breastfeeding in this population of women. Regardless of therapy received, breastfeeding duration in this study of preterm mothers was poor. I.
Article
To test the hypothesis that metformin during lactation versus formula feeding would have no adverse effects on infants' growth, motor-social development, or intercurrent illness. Growth, motor-social development, and illness requiring a pediatrician visit were assessed in 61 nursing infants (21 male, 40 female) and 50 formula-fed infants (19 male, 31 female) born to 92 mothers with polycystic ovary syndrome (PCOS) taking a median of 2.55 g metformin per day throughout pregnancy and lactation. Within sex, at 3 and 6 months of age, weight, height, and motor-social development did not differ (p > or = .06) between breast- and formula-fed infants. No infants had retardation of growth, motor, or social development. Intercurrent illnesses did not differ. Metformin during lactation appears to be safe and effective in the first 6 months of infancy.